The diagnosis question: is this confirmed DLBCL, and on what evidence?
Lymphoma is not one disease. The National Cancer Institute notes that lymphoma includes Hodgkin and non-Hodgkin types, and that the exact diagnosis matters when treatment is discussed. Diffuse large B-cell lymphoma sits within the non-Hodgkin group, but even inside that name there are distinctions a treating team may need before commenting on care.
If the pathology report is absent, a China specialist cannot see which tissue was sampled, which laboratory issued the report, or whether the wording describes DLBCL specifically rather than a broader lymphoma category. A discharge summary that says only 'lymphoma' leaves the diagnosis question open.
Biomarker and molecular reports matter for a different reason. They may show which cell markers were tested, whether subtyping was attempted, and whether any results were inconclusive. Without them, a reviewer cannot tell whether subtyping is complete, pending, or was never requested. That is not a reason to delay your current care; it is a reason to ask what the existing file actually contains.
A practical action is to request the original pathology report, not only a translated summary, plus any immunohistochemistry or molecular addendum. If the report exists only in another language, ask whether a certified translation is available. Then ask the receiving clinician one direct question: does this file confirm DLBCL, and is any further pathology clarification needed before a treatment discussion?
The treatment-history question: what was given, and what happened?
A diagnosis alone does not describe where you are in the disease course. A specialist reviewing records from abroad needs to know what treatment has already been given, when it was given, and how the disease responded. If those documents are missing, the review cannot distinguish between someone who has never been treated, someone in the middle of a planned course, and someone whose disease has come back after treatment.
Treatment summaries are often the weakest part of a transferred file. They may list drug names without dates, omit the number of cycles completed, or leave out whether a course was stopped early and why. Imaging reports may describe response in local wording that is hard to interpret without the original scans or the radiologist's full report.
The consequence is concrete. A reviewer who cannot see prior regimens cannot comment on what options have already been tried, what was tolerated, or what questions a new team should ask. That does not mean the missing information can be reconstructed from memory; it means the file should be clarified before anyone treats it as complete.
Ask your current treating team for a chronological treatment summary: regimen names as written in the record, start and stop dates, cycles completed, response assessments, and reason for any change. Request the corresponding imaging and laboratory reports, not only the final impression. If a document genuinely does not exist, say so explicitly rather than leaving a gap that a reviewer may misread.
The relapse question: is this newly diagnosed, refractory or relapsed disease?
An incomplete file can leave the disease setting unclear. Newly diagnosed, refractory and relapsed disease are different clinical situations, and a records-based opinion depends on knowing which one applies. If the file does not establish that, a China specialist can only speak in general terms.
The evidence for relapse usually sits in follow-up imaging, biopsy results and clinical notes. If the most recent assessment is missing, a reviewer cannot tell whether the disease is responding, stable, or progressing. If a repeat biopsy was done, its pathology report is essential because it may confirm the same diagnosis or raise a different one.
A missing answer here changes what a review can honestly deliver. It may still identify what information is needed and which specialty should see the case, but it cannot confirm eligibility for any particular treatment, trial or procedure. Those decisions belong to the treating hospital after it has the full picture.
A useful action is to ask your treating clinician to state, in writing, the current disease status and the evidence supporting it. Request the most recent imaging reports and any biopsy reports from the current phase. If the status is genuinely uncertain, that uncertainty should be recorded rather than smoothed over.
What a China specialist review can and cannot answer without those records
A records-based review is a clinical opinion, not a diagnosis made from a distance and not a guarantee of hospital acceptance. With a complete file, a specialist can comment on the diagnosis as documented, the treatment history, the current status, and what questions the next treating team should address. With an incomplete file, the same specialist can still identify gaps and suggest what to obtain, but the clinical conclusions remain provisional.
This distinction matters for planning. A review that says 'this case appears suitable for further assessment' is not the same as an offer of treatment, a place in a clinical trial, or a confirmed appointment. Eligibility for trials, transplantation or specific therapies is decided by the treating institution after its own assessment, and it depends on criteria that a records review alone cannot settle.
It also matters for cost and timing questions. Without knowing the diagnosis, prior treatment and current status, no one can give a meaningful estimate of what care might involve. If you receive a figure before those questions are answered, ask what it is based on and what it excludes.
The practical step is to treat the review as a way to organise the file and frame the next conversation, not as a final answer. Ask the reviewer to list, in writing, which records were used, which were missing, and which questions remain open.
How to prepare a usable file before you contact anyone
The goal is not to send everything you own. It is to send a short, accurate summary that lets a clinician see the shape of the case, followed by the key documents that support it. A pathologist's report, a treatment chronology and the most recent assessment are usually more useful than a large unsorted archive.
Start with a one-page summary in English: the diagnosis as written, the date it was confirmed, the treatment received to date, the current status, and your main question. Then attach the original pathology report, the treatment summary, and the latest imaging and laboratory reports. If a document is missing, list it as missing rather than omitting it silently.
Translation is a practical issue. Ask whether the receiving clinician needs a certified translation or whether a clear summary is enough for an initial review. Do not send passport numbers, payment details or a complete medical archive through an initial enquiry form; a brief summary is enough to begin.
If you want help with records, interpretation or requesting a specialist appointment, that coordination can be discussed separately. It does not replace the treating clinician's assessment, and an initial enquiry does not require buying a proxy consultation.
- One-page English summary: diagnosis, date, treatment to date, current status, main question.
- Original pathology report plus any biomarker or molecular addendum.
- Chronological treatment summary with regimen names, dates, cycles and response.
- Most recent imaging and laboratory reports, with the radiologist's full report.
- A written list of documents that are missing or unavailable.
What to do if a record cannot be obtained
Some records genuinely cannot be retrieved: a hospital has closed, a laboratory no longer holds the sample, or a report was never issued in writing. That does not automatically block a review. It does change what the review can conclude, and the honest response is to record the gap rather than fill it with an assumption.
If the pathology report is unavailable, ask whether a repeat biopsy or a pathology re-review is clinically appropriate. That is a decision for the treating clinician, not something to arrange independently. If prior treatment records are unavailable, a written patient history may help, but it should be labelled as patient-reported rather than treated as a clinical record.
If the current disease status is unclear, the priority is local assessment, not overseas planning. Worsening symptoms need prompt local medical attention, and an overseas enquiry should not delay that. Once the local picture is clearer, the file can be updated and reviewed again.
The next step is to send a brief summary through the enquiry form, email or WhatsApp. The team can check what is available, point out what is missing, and suggest the relevant next step. That initial enquiry is free, and the hospital decides suitability after it sees the case.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.